EUVIMEDEUVIMED entdecken
Multizentrische Studie

Radiomic biomarkers for the recurrence prediction of hepatocellular carcinoma treated with postoperative TACE: A multicenter retrospective study

Lingling Zhou, Liyun Zheng, Kun Zhang, Xinyu Guo, Chaoming Huang, Lingyi Zhu, Shuang Liu, Zhongwei Zhao, Jianfei Tu, Shiman Zhu, Yanci Zhao, Feng Chen und 5 weitere

European Journal of Radiology · 2025

DOI: 10.1016/j.ejrad.2025.112442 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Radiology, 2025. Verfasst von Lingling Zhou und 16 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Imaging and Interventional Medicine, Lishui Hospital, School of Medicine, Zhejiang University, Lishui, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic, Neoplasm Recurrence, Local. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The study aims to evaluate the value of radiomics signature in predicting the recurrence risk in hepatocellular carcinoma (HCC) patients treated with postoperative adjuvant transarterial chemoembolization (PA-TACE). PATIENTS AND METHODS: In this retrospective study, 204 HCC patients treated with PA-TACE between November 2014 and May 2023 from three centers were included and stratified into the training (n = 91), the internal(n = 21) and external validation cohorts (n = 92). Based on multi-parametric magnetic resonance imaging (mpMRI), radiomics features were extracted and radiomics models were established by using 101 combinations of 10 machine learning algorithms. The most valuable radiomics model with the highest average C-index was identified and subsequently used to calculate the Rad-score. All patients were then stratified into low- and high-risk radiomics signature (LRS and HRS) groups based on the median value of the Rad-score and subgroup analyses were performed to explore the potential association between recurrence risk and benefit from PA-TACE. Furthermore, a combined nomogram was subsequently developed by integrating the Rad-score with relevant clinicopathological variables. RESULTS: The radiomics model developed by CoxBoost + survival-SVM method was regarded as the optimal model with C-index (95 % CI) of 0.828 (0.777-0.879), 0.796 (0.622-0.933), and 0.718 (0.647-0.781) in three cohorts. The RFS of the HRS group was superior to that of the LRS group in the training(52.4 months v.s. 27.5 months; P < 0.0001) and external validation cohorts(45.8 months v.s. 43.0 months; P < 0.0001). The combined nomogram presented better predictive performance in the training set (0.848, 0.793-0.903), internal validation (0.825, 0.689-0.962) and external validation (0.722, 0.657-0.787). The decision curve analysis indicated that the combined nomogram had relatively higher clinical net benefits. CONCLUSION: mpMRI-based radiomics features are associated with recurrence risk in HCC patients receiving PA-TACE and may serve as the potential imaging biomarkers for stratifying candidates who are more likely benefit from PA-TACE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsChemoembolization, TherapeuticNeoplasm Recurrence, LocalMagnetic Resonance ImagingHumansRetrospective StudiesMaleFemaleMiddle AgedAgedNomogramsRadiomics

Stichwörter der Autor:innen

Hepatocellular carcinomaMulti-parametric magnetic resonance imagingPostoperative adjuvant transcatheter arterial chemoembolizationRadiomicsRecurrence

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Imaging and Interventional Medicine, Lishui Hospital, School of Medicine, Zhejiang University, Lishui, China.
  • Zhejiang Key Laboratory of Imaging and Interventional Medicine, Lishui Hospital, School of Medicine, Zhejiang University, Lishui, China; Department of Radiology, Lishui Central Hospital, the Fifth Affiliated Hospital of…
  • Department of Radiology, the First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
  • Department of Radiology, the First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China. Electronic address: xiaowb.111@163.com.

Zitieren

APA

Zhou, L., Zheng, L., Zhang, K., Guo, X., Huang, C., Zhu, L., Liu, S., Zhao, Z., Tu, J., Zhu, S., Zhao, Y., Chen, F., Chen, M., Xu, M., Chen, W., Xiao, W., & Ji, J. (2025). Radiomic biomarkers for the recurrence prediction of hepatocellular carcinoma treated with postoperative TACE: A multicenter retrospective study. European Journal of Radiology. https://doi.org/10.1016/j.ejrad.2025.112442

Vancouver

Zhou L, Zheng L, Zhang K, Guo X, Huang C, Zhu L, et al. Radiomic biomarkers for the recurrence prediction of hepatocellular carcinoma treated with postoperative TACE: A multicenter retrospective study. European Journal of Radiology. 2025. doi:10.1016/j.ejrad.2025.112442

BibTeX
@article{Zhou2025,
  author = {Zhou, Lingling and Zheng, Liyun and Zhang, Kun and Guo, Xinyu and Huang, Chaoming and Zhu, Lingyi and Liu, Shuang and Zhao, Zhongwei and Tu, Jianfei and Zhu, Shiman and Zhao, Yanci and Chen, Feng and Chen, Minjiang and Xu, Min and Chen, Weiqian and Xiao, Wenbo and Ji, Jiansong},
  title = {Radiomic biomarkers for the recurrence prediction of hepatocellular carcinoma treated with postoperative TACE: A multicenter retrospective study},
  journal = {European Journal of Radiology},
  year = {2025},
  doi = {10.1016/j.ejrad.2025.112442}
}
Kostenlos starten →